Testing how genetic factors can improve medication effectiveness in underserved populations
Preemptive pharmacogenetic testing in medically underserved populations
This study is looking at how testing your genes can help doctors find the best and most affordable medications for people in underserved communities, making it easier for them to get the right treatment without as many trips to the doctor.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10878972 on NIH RePORTER |
What this research studies
This research investigates the use of preemptive pharmacogenetic testing to enhance drug therapy in medically underserved populations. By identifying genetic variations that affect how patients respond to medications, the study aims to reduce the number of doctor visits needed to find the right treatment and improve the effectiveness of affordable off-patent drugs. The research will analyze prescribing patterns and assess the feasibility of implementing pharmacogenetic testing in these communities to ensure better medication outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from medically underserved communities who are prescribed medications that may be influenced by genetic factors.
Not a fit: Patients who are not from medically underserved populations or those not taking medications affected by pharmacogenetic variations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized medication treatments for patients in underserved populations.
How similar studies have performed: Previous research has shown that pharmacogenetic testing can improve medication outcomes, particularly in diverse populations, suggesting a promising approach for this study.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Duarte, Julio David — University of Florida
- Study coordinator: Duarte, Julio David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.